Search
forResearch 10 of 75
- Monitoring chemotherapy‐induced alopecia with trichoscopy
- ORAL TARGETED THERAPY-INDUCED CUTANEOUS TOXICITY: LIFE EXPERIENCE OF PATIENTS WITH ADVANCED LUNG CANCER IN TAIWAN
- Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients
- Efficacy and tolerability of scalp cooling in preventing alopecia during (neo)adjuvant chemotherapy for breast cancer
- The effect of a helmet type, home-use low-level light therapy device for chemotherapy-induced alopecia: study protocol for a randomized controlled trial
- Management of Alopecia Due to Cancer Therapies
- Dermatological adverse events with taxane chemotherapy
- Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: Clinicopathologic findings in a cohort of 10 patients
- Why Do Not All Chemotherapy Patients Lose Their Hair? Answering an Intriguing Question
- Presentation, impact and prevention of chemotherapy-induced hair loss: scalp cooling potentials and limitations
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →